Michael Roost Clausen
- Pathology and Forensic Medicine top 2%
- Oncology top 5%
- Genetics top 5%
- Radiology, Nuclear Medicine and Imaging top 10%
- Immunology
- Co-authors
- Kim LintonMartin HutchingsFrancesco d’AmoreMartine E.D. ChamuleauPieternella J. LugtenburgDena DeMarcoTarec Christoffer El‐GalalyBrian Elliott
- Topics
- Lymphoma Diagnosis and Treatment (61 papers)Chronic Lymphocytic Leukemia Research (28 papers)CAR-T cell therapy research (27 papers)
- Journals
- The LancetJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- DenmarkUnited StatesUnited Kingdom
In The Last Decade
Michael Roost Clausen
68 papers receiving 826 citations
Hit Papers
Peers
Comparison fields: 5 of 62
- Pathology and Forensic Medicine 589
- Oncology 536
- Genetics 163
- Radiology, Nuclear Medicine and Imaging 147
- Immunology 126
Countries citing papers authored by Michael Roost Clausen
This map shows the geographic impact of Michael Roost Clausen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Roost Clausen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Roost Clausen more than expected).
Fields of papers citing papers by Michael Roost Clausen
This network shows the impact of papers produced by Michael Roost Clausen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Roost Clausen. The network helps show where Michael Roost Clausen may publish in the future.
Co-authorship network of co-authors of Michael Roost Clausen
This figure shows the co-authorship network connecting the top 25 collaborators of Michael Roost Clausen. A scholar is included among the top collaborators of Michael Roost Clausen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Roost Clausen. Michael Roost Clausen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 5 | |
| 7 | 8 | |
| 8 | 2 | |
| 9 | 7 | |
| 10 | 4 | |
| 11 | 4 | |
| 12 | 2 | |
| 13 | 2 | |
| 14 | 1 | |
| 15 | 2 | |
| 16 | 1 | |
| 17 | 6 | |
| 18 | 7 | |
| 19 | 7 | |
| 20 | Patient-reported symptoms are still the single most important factor for detecting lymphoma relapse | 1 |
About Michael Roost Clausen
Michael Roost Clausen is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 79 papers that have together received 834 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (61 papers), Chronic Lymphocytic Leukemia Research (28 papers) and CAR-T cell therapy research (27 papers). The work is most often cited by research in Pathology and Forensic Medicine (589 citations), Oncology (536 citations) and Genetics (163 citations). Michael Roost Clausen has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Kim Linton, Martin Hutchings, Francesco d’Amore, Martine E.D. Chamuleau, Pieternella J. Lugtenburg, Dena DeMarco, Tarec Christoffer El‐Galaly, Brian Elliott, Rogier Mous and Peter Johnson. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.